U.S., AstraZeneca strike deal for COVID-19 antibody treatment touted by Trump
By Ragnar in Health
Updated 4 years ago
The U.S. government has awarded $486 million to AstraZeneca Plc to develop and secure supplies of up to 100,000 doses of COVID-19 antibody treatment, a similar class of drug that was used in treating President Donald Trump.
